Participating Companies

Eli Lilly and Company

Lilly unites caring with discovery to make life better for people around the world. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. We were founded in 1876 by Colonel Eli Lilly, a man committed to creating high-quality medicines that meet real needs. More than a century later, we are passionate about building on this precedent in our continued pursuit to make life better for individuals, communities, and the world around us.

Management meeting request - click here

Presenter - Josh Smiley, SVP, Controller and CFO of Lilly Research Laboratories

Josh began his Lilly career in 1995 and has held positions across Finance, Sales and Marketing and Six Sigma.  Joshua was named Vice President and CFO for Lilly Research Laboratories in April, 2007.  In June of 2011, he was promoted to Senior Vice President, Finance.  In this capacity, Josh serves as the Corporate Controller with responsibility for world-wide financial operations and CFO for Lilly Research Laboratories.  Previously, Josh was a member of Lilly’s corporate Six Sigma initial deployment and leadership team where he had responsibility for Six Sigma efforts across G&A functions including Finance, HR, Legal, Corporate Affairs, IT and Elanco.  Prior to his Six Sigma role, Josh led our U.S. sales and marketing efforts to government payers such as Medicaid, Medicare, the VA, nursing homes and public hospitals.

Josh earned a Bachelor of Arts degree in History from Harvard University in 1993.  Prior to joining Lilly, Josh worked in investment banking and consulting.  In 2005, he was named by Citigroup and Treasury and Risk Management publications to their annual “40 Under 40” Outstanding Finance Executives.  Josh is a member of the Board of Trustees for Butler University and the Indiana Chamber of Commerce.



John C. Lechleiter, Chairman of the Board, President and Chief Executive Officer

Derica W. Rice, Executive Vice President - Global Services and Chief Financial Officer

Investor Relations:
Philip L. Johnson, VP-IR, 317-655-6874

Visit Eli Lilly and Company at

Investor relations for Eli Lilly and Company can be reached here